The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

[ad_1] The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 … Read More

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

[ad_1] The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 … Read More

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

[ad_1] As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s … Read More

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

[ad_1] Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback … Read More

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

[ad_1] We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim … Read More

Biden administration’s Medicare drug price negotiations will face major tests in 2024

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna … Read More

Here are the big health sector themes to watch next year

[ad_1] An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out … Read More

If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

[ad_1] Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all … Read More